LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | GW843682X | 0.37 | uM | LJP6 | 72 | hr | 1694 | 5668 | 11217 | 0.5053 | 0.5570 |
MCF 10A | GW843682X | 1.11 | uM | LJP6 | 72 | hr | 1694 | 1859 | 11217 | 0.1657 | 0.0341 |
MCF 10A | GW843682X | 3.33 | uM | LJP6 | 72 | hr | 1694 | 970 | 11217 | 0.0865 | -0.1851 |
MCF 10A | GW843682X | 10 | uM | LJP6 | 72 | hr | 1694 | 715 | 11217 | 0.0638 | -0.2712 |
MCF 10A | HG-5-113-01 | 0.04 | uM | LJP5 | 72 | hr | 1694 | 10424 | 11103 | 0.9389 | 0.9538 |
MCF 10A | HG-5-113-01 | 0.12 | uM | LJP5 | 72 | hr | 1694 | 9608 | 11103 | 0.8654 | 0.8957 |
MCF 10A | HG-5-113-01 | 0.37 | uM | LJP5 | 72 | hr | 1694 | 8904 | 11103 | 0.8019 | 0.8435 |
MCF 10A | HG-5-113-01 | 1.11 | uM | LJP5 | 72 | hr | 1694 | 7639 | 11103 | 0.6880 | 0.7424 |
MCF 10A | HG-5-113-01 | 3.33 | uM | LJP5 | 72 | hr | 1694 | 5021 | 11103 | 0.4523 | 0.4926 |
MCF 10A | HG-5-113-01 | 10 | uM | LJP5 | 72 | hr | 1694 | 1256 | 11103 | 0.1132 | -0.1045 |
MCF 10A | HG-5-88-01 | 0.04 | uM | LJP6 | 72 | hr | 1694 | 10451 | 11217 | 0.9317 | 0.9488 |
MCF 10A | HG-5-88-01 | 0.12 | uM | LJP6 | 72 | hr | 1694 | 9945 | 11217 | 0.8866 | 0.9136 |
MCF 10A | HG-5-88-01 | 0.37 | uM | LJP6 | 72 | hr | 1694 | 8518 | 11217 | 0.7594 | 0.8080 |
MCF 10A | HG-5-88-01 | 1.11 | uM | LJP6 | 72 | hr | 1694 | 7479 | 11217 | 0.6669 | 0.7238 |
MCF 10A | HG-5-88-01 | 3.33 | uM | LJP6 | 72 | hr | 1694 | 6402 | 11217 | 0.5708 | 0.6283 |
MCF 10A | HG-5-88-01 | 10 | uM | LJP6 | 72 | hr | 1694 | 5518 | 11217 | 0.4919 | 0.5418 |
MCF 10A | HG-6-64-01 | 0.04 | uM | LJP6 | 72 | hr | 1694 | 11289 | 11217 | 1.0063 | 1.0044 |
MCF 10A | HG-6-64-01 | 0.12 | uM | LJP6 | 72 | hr | 1694 | 11177 | 11217 | 0.9963 | 0.9970 |
MCF 10A | HG-6-64-01 | 0.37 | uM | LJP6 | 72 | hr | 1694 | 11323 | 11217 | 1.0095 | 1.0069 |
MCF 10A | HG-6-64-01 | 1.11 | uM | LJP6 | 72 | hr | 1694 | 10460 | 11217 | 0.9326 | 0.9494 |
MCF 10A | HG-6-64-01 | 3.33 | uM | LJP6 | 72 | hr | 1694 | 7100 | 11217 | 0.6328 | 0.6893 |
MCF 10A | HG-6-64-01 | 10 | uM | LJP6 | 72 | hr | 1694 | 2052 | 11217 | 0.1827 | 0.0528 |
MCF 10A | Neratinib | 0.04 | uM | LJP5 | 72 | hr | 1694 | 5640 | 11103 | 0.5080 | 0.5576 |
MCF 10A | Neratinib | 0.12 | uM | LJP5 | 72 | hr | 1694 | 4371 | 11103 | 0.3937 | 0.4181 |
MCF 10A | Neratinib | 0.37 | uM | LJP5 | 72 | hr | 1694 | 3558 | 11103 | 0.3205 | 0.3144 |